Sichuan Kelun-Biotech Biopharmaceutical has reported published Phase III results for trastuzumab botidotin in patients w...
Johnson & Johnson has reported final overall survival results from the Phase III PAPILLON study evaluating first-lin...
Indian biopharma firm Biocon has announced the signing of partnership agreement with Bahiafarma and Bionovis for Pe...
Teijin Limited, Teijin Regenet Co., Ltd., and Shinshu University Hospital have entered into a joint research agreement r...
China Medical System Holdings has announced that initial prescriptions for Silevimig Injection have been issued at multi...
Indian biotechnology company Immunoscript Life Science will receive up to $8.9 million from Norway-based Coalition for E...
BioSpectrum Asia has published The CEO Handbook 2026, a seventy two page Career Spotlight edition profiling fifty chief ...
Korea Advanced Institute of Science and Technology (KAIST) has partnered with Thermo Fisher Scientific to establish SHAR...
Researchers from the National University of Singapore (NUS) have demonstrated an innovative approach for targeted breast...
Ascletis Pharma has initiated a US Phase I clinical study of ASC36 oral tablets, an investigational amylin receptor pept...
Kelun-Biotech has reported positive interim Phase II results for SKB378/WIN378, an investigational ultra-long-acting mon...
Alebund Pharmaceuticals has received clearance from the US Food and Drug Administration for the Investigational New Drug...
For children born with cleft lip and palate, repairing gaps in the jawbone often means waiting until they are 10 to 12 y...
Singapore has spent decades building the foundations of a global biomedical hub. The more difficult task now is not to s...
Hutchmed (China) has announced that its subsidiary, Hutchmed Limited has entered into an exclusive development and ...
Scientists from Nanyang Technological University (NTU), Singapore have developed microscopic peptide droplets that deliv...
South Korea based Alteogen Inc. has entered into an option and license agreement with Novartis for the development and c...
Biocytogen Pharmaceuticals (Beijing) has entered into a non-exclusive licensing agreement with Qilu Pharmaceutical for a...
Before we discuss the market, can you tell us about your role and what drew you to this area of healthcare logistics? I...
Osivax, a France based clinical-stage biopharmaceutical company developing differentiated influenza vaccines designed to...
Simcere Zaiming, a subsidiary of China-based Simcere Pharmaceutical Group, has entered into an exclusive global licensin...
Shanghai-based DualityBio has entered a global collaboration and licensing agreement with Genentech to develop next-gene...
CanSino Biologics reported continued momentum in its international business during the first half of 2026, alongside pro...
Antengene has received approval in Australia to initiate a Phase I clinical study of ATG-201, its investigational CD19/C...
Global multi-omics leader Novogene is establishing its first Australian laboratory at Cabrini Health, bringing advanced ...
